Log in to save to my catalogue

Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleuk...

Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleuk...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_35166995

Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response

About this item

Full title

Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response

Publisher

United States

Journal title

Pharmaceutical research, 2022-02, Vol.39 (2), p.353

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

The invention and application of new immunotherapeutic methods can compensate for the inefficiency of conventional cancer treatment approaches, partly due to the inhibitory microenvironment of the tumor. In this study, we tried to inhibit the growth of cancer cells and induce anti-tumor immune responses by silencing the expression of the β-catenin...

Alternative Titles

Full title

Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_35166995

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_35166995

Other Identifiers

E-ISSN

1573-904X

DOI

10.1007/s11095-022-03169-2

How to access this item